Probably BTX 1801 results are worthless as the results were far from what would be called a grant success. The eradication of Staf did not last long and this is not clinically useful. I think none of the pharmaceuticals may want to touch this thing unless they can prove it with more robust studies.
BOT - Anything but charting, page-1842
-
- There are more pages in this discussion • 7,495 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
-0.005(1.32%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.5¢ | 37.0¢ | $410.8K | 1.101M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 672032 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 200000 | 1 |
View Market Depth
| Last trade - 10.30am 19/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |